Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

PHGE

BiomX (PHGE)

BiomX Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:PHGE
DatumZeitQuelleÜberschriftSymbolFirma
16/12/202414h00GlobeNewswire Inc.BiomX Inc. Receives Notice of Compliance with NYSE American Continued Listing StandardsAMEX:PHGEBiomX Inc
14/11/202422h48Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:PHGEBiomX Inc
14/11/202412h30GlobeNewswire Inc.BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program UpdatesAMEX:PHGEBiomX Inc
12/11/202418h20GlobeNewswire Inc.BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024AMEX:PHGEBiomX Inc
15/10/202413h00GlobeNewswire Inc.BiomX Announces a Mandatory Unit SeparationAMEX:PHGEBiomX Inc
18/09/202422h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PHGEBiomX Inc
18/09/202422h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PHGEBiomX Inc
18/09/202422h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PHGEBiomX Inc
18/09/202414h00GlobeNewswire Inc.BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis ConferenceAMEX:PHGEBiomX Inc
04/09/202414h00GlobeNewswire Inc.BiomX to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceAMEX:PHGEBiomX Inc
03/09/202414h00GlobeNewswire Inc.BiomX to Present Positive Phase 1b/2a Clinical Trial Data for BX004 at the European Respiratory Society (ERS) Congress 2024AMEX:PHGEBiomX Inc
16/08/202422h30Edgar (US Regulatory)Form 8-K - Current reportAMEX:PHGEBiomX Inc
16/08/202416h55GlobeNewswire Inc.UPDATE ON UNITS - BiomX Inc. Announces 1-for-10 Reverse Stock SplitAMEX:PHGEBiomX Inc
15/08/202412h30GlobeNewswire Inc.BiomX Reports Second Quarter 2024 Financial Results and Provides Business and Program UpdatesAMEX:PHGEBiomX Inc
15/08/202412h30GlobeNewswire Inc.BiomX Inc. Announces 1-for-10 Reverse Stock SplitAMEX:PHGEBiomX Inc
14/08/202422h03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:PHGEBiomX Inc
08/08/202413h00GlobeNewswire Inc.BiomX to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 15, 2024AMEX:PHGEBiomX Inc
29/07/202414h11Edgar (US Regulatory)Form 8-K - Current reportAMEX:PHGEBiomX Inc
29/07/202413h00GlobeNewswire Inc.BiomX Inc. Announces NYSE American Acceptance of Plan to Regain Listing ComplianceAMEX:PHGEBiomX Inc
16/07/202421h34Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:PHGEBiomX Inc
16/07/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:PHGEBiomX Inc
16/07/202400h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PHGEBiomX Inc
16/07/202400h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PHGEBiomX Inc
16/07/202400h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PHGEBiomX Inc
16/07/202400h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PHGEBiomX Inc
16/07/202400h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PHGEBiomX Inc
16/07/202400h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PHGEBiomX Inc
16/07/202400h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PHGEBiomX Inc
16/07/202400h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PHGEBiomX Inc
16/07/202400h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PHGEBiomX Inc
 Showing the most relevant articles for your search:AMEX:PHGE